HV Bancorp (NASDAQ:HVBC) reported quarterly earnings of $0.14 per share. This is a 17.65 percent decrease over earnings of $0.17 per share from the same period last year.
BetterLife’s Non-Hallucinogenic LSD’s Clinical Studies, Braxia’s Psychedelic Treatments Continue
Psychedelics biotech BetterLife Pharma (OTCQB: BETRF) announced its non-hallucinogenic LSD derivative, BETR-001, is progressing through IND-enabling studies toward expected clinical studies targeting Major Depressive Disorder (MDD.)
